Fundraising FoxBoyu Capital — Full Portfolio
8 tracked investments · listed companies and verified rows first
Insurance platform (NYSE: WDH)
Co-investorsATM CapitalZhenFundGaorong CapitalGaorong Ventures
Frontera Therapeutics is a biotechnology company engaged in therapeutic research and development, spanning translational medicine, clinical operations, and manufacturing.
BiotechDeep TechHealthtechBoston, US
Xinyan Li(CEO)
Co-investorsOrbiMedCreacion VenturesHongShan Capital Group6 Dimensions Capital
Abogen Biosciences is a clinical-stage biotechnology company developing RNA-based medicines, with in-house capabilities spanning the full mRNA drug development cycle including protein engineering, mRNA sequence design and synthesis, lipid nanoparticle delivery, formulation, and commercial-scale manufacturing.
BiotechDeep TechHealthtech
Bo Ying(Founder)
Co-investors5Y CapitalCoatue ManagementFuzhou Jiebao Rongan Venture CapitalQiming Venture PartnersSoftBank Vision FundGL Ventures+7 more
Antengene is a biopharmaceutical company that develops therapies for cancer, with a pipeline focused on hematologic malignancies and solid tumors including Claudin 18.2, CD73, PD-L1/4-1BB bispecific, and CD24-targeting candidates.
BiotechHealthtech
Jay Mei(Founder)
Co-investorsDecheng CapitalQiming Venture PartnersFountainVest Partners
Hong Kong-listed (2137.HK) biotech founded in 2018 developing infectious disease therapies, led by hepatitis B functional-cure programs.
Co-investorsARCH Venture Partners6 Dimensions CapitalBlue Pool CapitalSequoia Capital
Hong Kong-listed (HKEX: 2616) Chinese biopharmaceutical company developing oncology, immunology and inflammation therapies.
Co-investorsARCH Venture Partners6 Dimensions CapitalGICHillhouse CapitalSequoia CapitalWuXi Healthcare Ventures
Trax provides retail intelligence and execution software for global CPG brands, using image recognition to analyze shelf images and report on on-shelf availability, share of shelf, pricing, and promotional compliance.
AI & Machine LearningRetail TechSaaS
Gary Laben(Chief Executive Officer)inJoel Bar-El(Co-founder)Dror Feldheim(Co-founder)
Co-investors1802 VenturesDigital HorizonDigital Horizon VCHaymaker VenturesSingha VenturesSmart Partnership Capital+9 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.